These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 13552361)

  • 21. [Intermittent carbutamide and tolbutamide therapy of diabetes in adults].
    BARENGHI G
    Minerva Med; 1958 Apr; 49(31):1476-7. PubMed ID: 13552298
    [No Abstract]   [Full Text] [Related]  

  • 22. [Clinical study of tolbutamide therapy of juvenile diabetes].
    BERTO R
    Minerva Med; 1958 Apr; 49(32):1546-7. PubMed ID: 13552363
    [No Abstract]   [Full Text] [Related]  

  • 23. Oral tolbutamide therapy of diabetes.
    SEGARRA FO; CHARIF BS; LORGE HJ
    Med Times; 1959 Aug; 87(8):988-95. PubMed ID: 13673725
    [No Abstract]   [Full Text] [Related]  

  • 24. Clinical investigation of hypoglycemic effect of seeds of Azadirachta-inidca in type-2 (NIDDM) diabetes mellitus.
    Waheed A; Miana GA; Ahmad SI
    Pak J Pharm Sci; 2006 Oct; 19(4):322-5. PubMed ID: 17105712
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Results of carbutamide and tolbutamide therapy of 204 cases of diabetes followed up for more than nine months].
    CUGUDDA E; GUAZZI B; MANCINI A
    Minerva Med; 1958 Apr; 49(31):1464-5. PubMed ID: 13552287
    [No Abstract]   [Full Text] [Related]  

  • 26. Cytochrome P450 2C9 *2 and *3 polymorphisms and the dose and effect of sulfonylurea in type II diabetes mellitus.
    Becker ML; Visser LE; Trienekens PH; Hofman A; van Schaik RH; Stricker BH
    Clin Pharmacol Ther; 2008 Feb; 83(2):288-92. PubMed ID: 17597710
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Amelioration of corticosteroid-induced type 2 diabetes mellitus by rosiglitazone is possibly mediated through stimulation of thyroid function and inhibition of tissue lipid peroxidation in mice.
    Jatwa R; Parmar HS; Panda S; Kar A
    Basic Clin Pharmacol Toxicol; 2007 Sep; 101(3):177-80. PubMed ID: 17697037
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardio-protective role of terazosin is possibly mediated through alteration in thyroid function.
    Jatwa R; Kar A
    Eur J Pharmacol; 2006 Dec; 551(1-3):87-91. PubMed ID: 17027746
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Type 2 diabetes mellitus: focus on new treatments and special populations.
    Del Prato S
    Int J Clin Pract Suppl; 2007 Aug; (154):1-2. PubMed ID: 17593271
    [No Abstract]   [Full Text] [Related]  

  • 30. [Statistical results on therapy of diabetes mellitus by synthetic hypoglycemic agents].
    UHRY P; MARCEL G; DUIZEND M; VARIN R; COHEN M; TEXIER
    Bull Mem Soc Med Hop Paris; 1957 Jun 14-21; 73(20-21):630-8. PubMed ID: 13460707
    [No Abstract]   [Full Text] [Related]  

  • 31. Modern therapy in diabetes mellitus, insulin, and the oral hypoglycemic agents.
    KIRTLEY WR; PECK FB
    Minn Med; 1958 Sep; 41(9):607-13. PubMed ID: 13577645
    [No Abstract]   [Full Text] [Related]  

  • 32. Glycaemic effects of incretins in Type 1 diabetes mellitus: a concise review, with emphasis on studies in humans.
    Dupre J
    Regul Pept; 2005 Jun; 128(2):149-57. PubMed ID: 15780434
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Indications and contraindications for oral hypoglycemic drug therapy of diabetes mellitus].
    CAVICCHI E
    Athena; 1958; 24(8-10):131-2. PubMed ID: 13607321
    [No Abstract]   [Full Text] [Related]  

  • 34. [Various negative aspects of hypoglycemic sulfonyl urea therapy of diabetes mellitus].
    TOLOMELLI E; BACCI L
    Minerva Med; 1958 Apr; 49(31):1473-4. PubMed ID: 13552295
    [No Abstract]   [Full Text] [Related]  

  • 35. [THE INDICATIONS FOR USE AND THE EFFECTIVENESS OF SULFANILAMIDE PREPARATIONS IN DIABETES MELLITUS].
    GUSMAN SM; ALEKPEROV MA
    Sov Med; 1963 May; 26():13-8. PubMed ID: 14073318
    [No Abstract]   [Full Text] [Related]  

  • 36. [Use of hypoglycemic substances (carbutamide and tolbutamide) in therapy of diabetic syndromes].
    BUTTARO CA; BRUNORI CA; BIANCONI B
    Minerva Med; 1958 Apr; 49(31):1474-5. PubMed ID: 13552296
    [No Abstract]   [Full Text] [Related]  

  • 37. [Peroral treatment of diabetes with tolbutamide].
    AARSETH S
    Tidsskr Nor Laegeforen; 1957 Dec; 77(24):1135-9. PubMed ID: 13529921
    [No Abstract]   [Full Text] [Related]  

  • 38. [A case of diabetes in pregnancy treated with tolbutamide].
    CAPPETTI CA; SIMONETTA R
    Minerva Med; 1958 Apr; 49(31):1485-7. PubMed ID: 13552307
    [No Abstract]   [Full Text] [Related]  

  • 39. Prolonged use of tolbutamide in the treatment of diabetes.
    ANDRADA JA; GURTMAN AI; EPSTEIN JA; KUPPERMAN HS
    Prensa Med Argent; 1957 Apr; 44(17):1273-80. PubMed ID: 13484732
    [No Abstract]   [Full Text] [Related]  

  • 40. The use of tolbutamide in the management of adult diabetes.
    SHERRY S; ZEFFREN JL; BRAVERMAN AE; DREY NW
    Ann N Y Acad Sci; 1957 Jul; 71(1):249-55. PubMed ID: 13459221
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.